OCBCO
FOLD

Oversea-Chinese Banking Corp (OCBC)’s Amicus Therapeutics FOLD Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-28,386
Closed -$347K – 342
2022
Q4 		$347K Buy
+28,386
New +$320K 0.02% 262

Other funds holding FOLD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s FOLD Position: Q1 2023 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of Amicus Therapeutics (FOLD) in Q1 2023, closing a stake of 28,386 shares — an estimated $347K sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in FOLD in Q4 2022 and held it in 1 quarter. The position peaked at $347K in Q4 2022. 226 funds tracked by Wall St. Rank hold FOLD as of Q1 2023.

  • Oversea-Chinese Banking Corp (OCBC) reported no remaining Amicus Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Oversea-Chinese Banking Corp (OCBC) sold 28,386 Amicus Therapeutics shares in Q1 2023, an estimated $347K.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in Amicus Therapeutics in Q4 2022 and held it in 1 quarter.
  • Oversea-Chinese Banking Corp (OCBC)'s Amicus Therapeutics position peaked at $347K in Q4 2022.
  • 226 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2023.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q1 2023, filed 4 May 2023.